SQSTM1 and central nervous system cancer: In detail, Deng et al. [15] have shown that overexpression of p62 endorsed glioma progression by promoting proliferation, migration, and glycolysis as well as temozolomide (TMZ) resistance and nuclear factor-κB (NF-κB) signalling pathway.